Share
Journal Information
Open Access
Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study
Jorge Luis Poo1,
, Julieta Góngora1, Francisco Sánchez-Ávila2, Sergio Aguilar-Castillo3, Guillermo García-Ramos3, Mario Fernández-Zertuche4, Lourdes Rodríguez-Fragoso5, Misael Uribe2
Corresponding author
1 Pharmacology Unit, Medica Sur Clinic and Foundation.
2 Liver Unit, Medica Sur Clinic and Foundation.
3 Neurophysyology Department, Medica Sur Clinic and Foundation.
4 Centro de Investigaciones Químicas Universidad Autónoma del Estado de Morelos.
5 Facultad de Farmacia Universidad Autónoma del Estado de Morelos.
Article
This article is available in English
Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study
Jorge Luis Poo, Julieta Góngora, Francisco Sánchez-Ávila, Sergio Aguilar-Castillo, Guillermo García-Ramos, Mario Fernández-Zertuche, Lourdes Rodríguez-Fragoso, Misael Uribe
10.1016/S1665-2681(19)31989-1Ann Hepatol. 2006;5:281-8
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
